BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 26648589)

  • 1. Monitoring the response of patients with cutaneous leishmaniasis to treatment with pentamidine isethionate by quantitative real-time PCR, and identification of Leishmania parasites not responding to therapy.
    Mans DR; Kent AD; Hu RV; Lai A Fat EJ; Schoone GJ; Adams ER; Rood EJ; Alba S; Sabajo LO; Lai A Fat RF; de Vries HJ; Schallig HD
    Clin Exp Dermatol; 2016 Aug; 41(6):610-5. PubMed ID: 26648589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure.
    Christen JR; Bourreau E; Demar M; Lightburn E; Couppié P; Ginouvès M; Prévot G; Gangneux JP; Savini H; de Laval F; Pommier de Santi V; Briolant S
    Travel Med Infect Dis; 2018; 24():31-36. PubMed ID: 29482012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of treatment with pentamidine for cutaneous leishmaniasis in Suriname.
    van der Meide WF; Sabajo LO; Jensema AJ; Peekel I; Faber WR; Schallig HD; Fat RF
    Int J Dermatol; 2009 Jan; 48(1):52-8. PubMed ID: 19126051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil.
    Romero GA; de la Glória Orge Orge M; de Farias Guerra MV; Paes MG; de Oliveira Macêdo V; de Carvalho EM
    Acta Trop; 2005 Jan; 93(1):49-56. PubMed ID: 15589797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First Molecular Report of
    Salvioni Recalde OD; Pereira Brunelli J; Rolon MS; Rojas de Arias A; Aldama O; Gómez CV
    Am J Trop Med Hyg; 2019 Oct; 101(4):780-788. PubMed ID: 31407656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
    Arevalo J; Ramirez L; Adaui V; Zimic M; Tulliano G; Miranda-Verástegui C; Lazo M; Loayza-Muro R; De Doncker S; Maurer A; Chappuis F; Dujardin JC; Llanos-Cuentas A
    J Infect Dis; 2007 Jun; 195(12):1846-51. PubMed ID: 17492601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Sensitivity of Cutaneous
    Ginouvès M; Simon S; Nacher M; Demar M; Carme B; Couppié P; Prévot G
    Am J Trop Med Hyg; 2017 May; 96(5):1143-1150. PubMed ID: 28167598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of real-time PCR assays for evaluation of immune response and parasite load in golden hamster (Mesocricetus auratus) infected by Leishmania (Viannia) braziliensis.
    Ribeiro-Romão RP; Saavedra AF; Da-Cruz AM; Pinto EF; Moreira OC
    Parasit Vectors; 2016 Jun; 9(1):361. PubMed ID: 27350537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First case of cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis in Suriname.
    Hu RV; Kent AD; Adams ER; van der Veer C; Sabajo LO; Mans DR; de Vries HJ; Schallig HD; Lai A Fat RF
    Am J Trop Med Hyg; 2012 May; 86(5):825-7. PubMed ID: 22556081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.
    Guerra JA; Prestes SR; Silveira H; Coelho LI; Gama P; Moura A; Amato V; Barbosa Md; Ferreira LC
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e980. PubMed ID: 21408116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species diversity causing human cutaneous leishmaniasis in Rio Branco, state of Acre, Brazil.
    Tojal da Silva AC; Cupolillo E; Volpini AC; Almeida R; Romero GA
    Trop Med Int Health; 2006 Sep; 11(9):1388-98. PubMed ID: 16930261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open label randomized clinical trial comparing the safety and effectiveness of one, two or three weekly pentamidine isethionate doses (seven milligrams per kilogram) in the treatment of cutaneous leishmaniasis in the Amazon Region.
    Gadelha EPN; Ramasawmy R; da Costa Oliveira B; Morais Rocha N; de Oliveira Guerra JA; Allan Villa Rouco da Silva G; Gabrielle Ramos de Mesquita T; Chrusciak Talhari Cortez C; Chrusciak Talhari A
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006850. PubMed ID: 30379814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.
    Francesquini FC; Silveira FT; Passero LF; Tomokane TY; Carvalho AK; Corbett CE; Laurenti MD
    Int J Exp Pathol; 2014 Dec; 95(6):418-26. PubMed ID: 25476864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rarity of infection with Leishmania (Viannia) braziliensis among patients from the Manaus region of Amazonas state, Brazil, who have cutaneous leishmaniasis.
    Romero GA; Ishikawa E; Cupolillo E; Toaldo CB; Guerra MV; Paes MG; Macêdo VO; Shaw JJ
    Ann Trop Med Parasitol; 2002 Mar; 96(2):131-6. PubMed ID: 12080973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of Leishmania spp. causing cutaneous leishmaniasis in the lower Amazon region, western Pará state, Brazil, reveals a putative hybrid parasite, Leishmania (Viannia) guyanensis × Leishmania (Viannia) shawi shawi.
    Jennings YL; de Souza AA; Ishikawa EA; Shaw J; Lainson R; Silveira F
    Parasite; 2014; 21():39. PubMed ID: 25083790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Biological Characterization of Leishmania (Viannia) guyanensis Isolated from a Patient with Tegumentary Leishmaniasis in Goiás, a Nonendemic Area for This Species in Brazil.
    Pires Ada S; Borges AF; Cappellazzo Coelho A; Dorta ML; Lino Junior Rde S; Pereira LI; Pinto SA; Pelli de Oliveira MA; de Matos GG; Abrahamsohn IA; Uliana SR; Lima GM; Ribeiro-Dias F
    Biomed Res Int; 2015; 2015():350764. PubMed ID: 26583102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial.
    Francesconi VA; Francesconi F; Ramasawmy R; Romero GAS; Alecrim MDGC
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006225. PubMed ID: 29481560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zosteriform cutaneous leishmaniasis due to Leishmania ( Viannia ) panamensis and Leishmania ( Viannia ) braziliensis: report of three cases.
    Morales CA; Palacio J; Rodríguez G; Camargo YC
    Biomedica; 2014; 34(3):340-4. PubMed ID: 25504121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed culture of Leishmania in skin biopsies.
    Dedet JP; Pratlong F; Pradinaud R; Moreau B
    Trans R Soc Trop Med Hyg; 1999; 93(6):673-4. PubMed ID: 10717763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
    Castro MD; Gomez MA; Kip AE; Cossio A; Ortiz E; Navas A; Dorlo TP; Saravia NG
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.